2022
DOI: 10.3389/fsurg.2022.986372
|View full text |Cite
|
Sign up to set email alerts
|

COL1A1 novel splice variant in osteogenesis imperfecta and splicing variants review: A case report

Abstract: BackgroundOsteogenesis imperfecta (OI) is a rare heterogeneous genetic disorder commonly autosomal dominant with variants in the COL1A1 and COL1A2 genes. It is characterized by bone fragility and deformity, recurrent fractures, blue sclera, dentinogenesis imperfecta, short stature, and progressive deafness.Case presentationWe present a novel splicing mutation in the COL1A1 gene (c.2398-1G > C) in a 6-year-old Ecuadorian girl with fractures after light pressure and blue sclera. We identified the pathogen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 11 publications
0
3
0
Order By: Relevance
“…A splice variant modifies the DNA sequence at the splice site, delineating the boundary between exons and introns. This modification can result in the inclusion of introns, the loss of exons, and a change in the protein-coding sequence, thereby disrupting the process of RNA splicing [ 21 ]. It can disrupt or diminish mRNA processing via exon skipping or cryptic splice-site activation [ 22 ].…”
Section: Discussionmentioning
confidence: 99%
“…A splice variant modifies the DNA sequence at the splice site, delineating the boundary between exons and introns. This modification can result in the inclusion of introns, the loss of exons, and a change in the protein-coding sequence, thereby disrupting the process of RNA splicing [ 21 ]. It can disrupt or diminish mRNA processing via exon skipping or cryptic splice-site activation [ 22 ].…”
Section: Discussionmentioning
confidence: 99%
“…In the present study, the RUNX2 and COL1A1 genes were examined to assess the extent of osteogenicity. COL1A1 is one of the early markers in the osteogenic differentiation process, and defects in this gene lead to fragile bones (Marom, Rabenhorst et al 2020, Dirani, Cuenca et al 2022). In vitro and in vivo studies show that RUNX2 controls the expression of the major bone matrix protein that resides in the promoter of several osteoblast-speci c genes (Liu and Lee 2013, Zhang and Li 2018).…”
Section: Discussionmentioning
confidence: 99%
“…The inclusion of BCS in the revised 2017 international Ehlers-Danlos Syndrome (EDS) classification emphasizes its connection with EDS [6,7]. In situations where a corneal rupture has not yet occurred, it can often be confused with other connective tissue diseases, such as Marfan syndrome [8,9], osteogenesis imperfecta (OI) [10,11], or kyphoscoliotic Ehlers-danlos syndrome (kEDS) [12][13][14]. Given the overlapping clinical presentations and pathophysiological features of these diseases, accurate identification and diagnosis in the early stages can often be challenging.…”
Section: Discussionmentioning
confidence: 99%